UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 176 filers reported holding UNIQURE NV in Q2 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5 | -28.6% | 1,114 | -21.9% | 0.00% | – |
Q1 2024 | $7 | -99.3% | 1,427 | -99.0% | 0.00% | – |
Q4 2023 | $1,012 | -84.8% | 149,469 | -84.9% | 0.00% | -100.0% |
Q3 2023 | $6,641 | +267.7% | 989,562 | +527.8% | 0.00% | +300.0% |
Q2 2023 | $1,806 | +32.9% | 157,633 | +133.6% | 0.00% | 0.0% |
Q1 2023 | $1,359 | -44.0% | 67,485 | -37.0% | 0.00% | 0.0% |
Q4 2022 | $2,427 | -99.9% | 107,045 | -22.9% | 0.00% | -66.7% |
Q3 2022 | $2,604,000 | +1371.2% | 138,790 | +1360.3% | 0.00% | – |
Q2 2022 | $177,000 | -58.3% | 9,504 | -59.4% | 0.00% | – |
Q1 2022 | $424,000 | +207.2% | 23,419 | +253.1% | 0.00% | – |
Q4 2021 | $138,000 | -80.0% | 6,632 | -69.2% | 0.00% | – |
Q3 2021 | $690,000 | +1990.9% | 21,560 | +1900.0% | 0.00% | – |
Q2 2021 | $33,000 | -90.5% | 1,078 | -89.5% | 0.00% | – |
Q1 2021 | $346,000 | -11.7% | 10,258 | -5.6% | 0.00% | – |
Q4 2020 | $392,000 | +2.6% | 10,863 | +4.6% | 0.00% | – |
Q3 2020 | $382,000 | -34.3% | 10,387 | -19.4% | 0.00% | – |
Q2 2020 | $581,000 | +28950.0% | 12,886 | +61261.9% | 0.00% | – |
Q4 2019 | $2,000 | -99.7% | 21 | -99.9% | 0.00% | – |
Q3 2019 | $610,000 | -75.6% | 15,501 | -51.6% | 0.00% | -100.0% |
Q2 2019 | $2,501,000 | +318.2% | 32,000 | +218.7% | 0.00% | – |
Q1 2019 | $598,000 | +834.4% | 10,040 | +351.8% | 0.00% | – |
Q4 2018 | $64,000 | -20.0% | 2,222 | +2.3% | 0.00% | – |
Q3 2018 | $80,000 | -89.3% | 2,171 | -89.0% | 0.00% | -100.0% |
Q2 2018 | $745,000 | -32.8% | 19,732 | -58.2% | 0.00% | 0.0% |
Q1 2018 | $1,109,000 | -19.1% | 47,239 | -32.5% | 0.00% | 0.0% |
Q4 2017 | $1,371,000 | +633.2% | 69,935 | +258.9% | 0.00% | – |
Q3 2017 | $187,000 | +18600.0% | 19,485 | +22823.5% | 0.00% | – |
Q2 2017 | $1,000 | -83.3% | 85 | -92.7% | 0.00% | – |
Q1 2017 | $6,000 | -72.7% | 1,161 | -71.2% | 0.00% | – |
Q4 2016 | $22,000 | +633.3% | 4,036 | +1087.1% | 0.00% | – |
Q2 2016 | $3,000 | +200.0% | 340 | +142.9% | 0.00% | – |
Q1 2016 | $1,000 | -97.3% | 140 | -93.9% | 0.00% | – |
Q4 2015 | $37,000 | – | 2,304 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 939,966 | $21,309,029 | 5.53% |
Aquilo Capital Management, LLC | 624,854 | $14,165,440 | 5.32% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 631,500 | $14,297,160 | 4.42% |
Nantahala Capital Management | 2,700,239 | $61,214,418 | 3.97% |
Integral Health Asset Management, LLC | 550,000 | $12,468,500 | 2.62% |
Privium Fund Management B.V. | 301,298 | $6,830,426 | 2.59% |
683 Capital Management, LLC | 1,145,000 | $25,957,150 | 2.20% |
PFM Health Sciences, LP | 2,302,314 | $52,193,458 | 1.87% |
Nantahala Capital Management | 1,187,700 | $26,925,159 | 1.74% |
Jetstream Capital LLC | 30,000 | $680,100 | 1.44% |